Drug
Tetrabenazine
Tetrabenazine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
1
25%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Other(2)
Detailed Status
Completed2
unknown2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed250%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Xenazine in Late Dyskinetic Syndrome With Neuroleptics
NCT01543321
unknown
Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
NCT00642057
unknownphase_4
A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
NCT02509793
completednot_applicable
Tetrabenazine for Partial Responders
NCT00362804
Clinical Trials (4)
Showing 4 of 4 trials
NCT01543321Phase 3
Xenazine in Late Dyskinetic Syndrome With Neuroleptics
NCT00642057
Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
NCT02509793Phase 4
A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
NCT00362804Not Applicable
Tetrabenazine for Partial Responders
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4